These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33128349)

  • 21. Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations.
    Patoulias D; Katsimardou A; Papadopoulos C; Doumas M
    Acta Diabetol; 2021 Jan; 58(1):125-126. PubMed ID: 32816107
    [No Abstract]   [Full Text] [Related]  

  • 22. Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study.
    Pantea Stoian A; Pricop-Jeckstadt M; Pana A; Ileanu BV; Schitea R; Geanta M; Catrinoiu D; Suceveanu AI; Serafinceanu C; Pituru S; Poiana C; Timar B; Nitipir C; Parvu S; Arsene A; Mazilu L; Toma A; Hainarosie R; Ceriello A; Rizzo M; Jinga V
    Sci Rep; 2020 Dec; 10(1):21613. PubMed ID: 33303885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide-Cohort Study (Diabetes Metab J 2020;44:737-46).
    Kim K; Oh TJ
    Diabetes Metab J; 2020 Dec; 44(6):938-939. PubMed ID: 33389961
    [No Abstract]   [Full Text] [Related]  

  • 24. Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.).
    Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A
    Diabetes Metab Syndr; 2020; 14(5):1147-1148. PubMed ID: 32668400
    [No Abstract]   [Full Text] [Related]  

  • 25. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.
    Pirola CJ; Sookoian S
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32407757
    [No Abstract]   [Full Text] [Related]  

  • 26. Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (
    Chung SM; Ahn JH; Moon JS
    Diabetes Metab J; 2020 Aug; 44(4):625-626. PubMed ID: 32856805
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019.
    Wilkinson RJ
    Clin Infect Dis; 2021 Jan; 72(1):79-81. PubMed ID: 32533824
    [No Abstract]   [Full Text] [Related]  

  • 28. Observational research on severe COVID-19 in diabetes.
    Stehouwer CDA
    Lancet Diabetes Endocrinol; 2021 Feb; 9(2):56-57. PubMed ID: 33357490
    [No Abstract]   [Full Text] [Related]  

  • 29. Response to Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398.
    Cai Q; Chen J; Xu L
    Diabetes Care; 2020 Oct; 43(10):e162. PubMed ID: 32958625
    [No Abstract]   [Full Text] [Related]  

  • 30. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.
    Mori J; Oudit GY; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severity of COVID-19 and diabetes mellitus: there is still a lot to be learned.
    Rodacki M
    Arch Endocrinol Metab; 2020; 64(3):195-196. PubMed ID: 32555983
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (
    Kim SY; Kim KS
    Diabetes Metab J; 2020 Aug; 44(4):621-622. PubMed ID: 32856803
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
    Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
    Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prioritising action on diabetes during COVID-19.
    Erzse A; Fraser H; Levitt N; Hofman K
    S Afr Med J; 2020 Jun; 110(8):719-720. PubMed ID: 32880294
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review.
    Singh AK; Khunti K
    Diabetes Res Clin Pract; 2020 Jul; 165():108266. PubMed ID: 32533989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes and COVID-19-the meeting of two pandemics: what are the concerns?
    Coppell KJ; Hall RM; Downie M; Fraser SK; Garrett M; Jefferies CA; Kenealy TW; Milne RE; Orr-Walker BJ; Paul RG; Smallman K; Snell HJ
    N Z Med J; 2020 May; 133(1514):85-87. PubMed ID: 32379745
    [No Abstract]   [Full Text] [Related]  

  • 38. "Does having diabetes increase chances of contracting COVID-19 infection?".
    Gangopadhyay KK
    Diabetes Metab Syndr; 2020; 14(5):765-766. PubMed ID: 32512520
    [No Abstract]   [Full Text] [Related]  

  • 39. Diabetes and covid-19: a global health challenge.
    Shenoy A; Ismaily M; Bajaj M
    BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32345580
    [No Abstract]   [Full Text] [Related]  

  • 40. Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis.
    Pinto LC; Bertoluci MC
    Arch Endocrinol Metab; 2020; 64(3):199-200. PubMed ID: 32555985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.